Assignee
KETABON GMBH
DE·2 granted patents·1 pending application·0 citations·filing 2021–2025
Top patents by PatentIndex Score
3 records- 0175US12239615B2Hydroxynorketamine for the use in the treatment of depressionKETABON GMBH·Filed 2023·Granted Mar 4, 2025·0 cites·18 claims
- 0266US12440456B2Method for treatment of depression with oral dosage forms of ketamineKETABON GMBH·Filed 2021·Granted Oct 14, 2025·0 cites·38 claims
- 0361US2025177325A1Hydroxynorketamine for the use in the treatment of depressionKETABON GMBH·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KETABON GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →